Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Daptomycin”

90 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 90 results

Not applicableStudy completedNCT00261807
What this trial is testing

Daptomycin for the Treatment of Severe Necrotizing Soft-Tissue Infections

Who this might be right for
Fasciitis, NecrotizingSevere Necrotizing Skin and Soft Tissue InfectionsFournier's Gangrene
University of Maryland, Baltimore 25
Post-approval studies (Phase 4)Study completedNCT01626560
What this trial is testing

The Effects of Daptomycin and Cytokines Production in Comparison With Vancomycin

Who this might be right for
Cellulitis
Hospital Universitario Evangelico de Curitiba 20
Testing effectiveness (Phase 2)Study completedNCT02052388
What this trial is testing

Efficacy and Safety Study of Brilacidin to Treat Serious Skin Infections

Who this might be right for
Skin InfectionBacterial Infection
Cellceutix Corporation 215
Post-approval studies (Phase 4)Study completedNCT00663403
What this trial is testing

Pharmacokinetics of Daptomycin in Critically Ill Patients Receiving Continuous Venovenous Hemodialysis (CVVHD)

Who this might be right for
Critically IllHemodialysis
University of Michigan 8
Post-approval studies (Phase 4)Ended earlyNCT00651131
What this trial is testing

Cubicin(R) for Complicated Post-surgical Wound Infections

Who this might be right for
Wound Infections
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 69
Testing effectiveness (Phase 2)Study completedNCT00426933
What this trial is testing

Phase 2 Safety and Efficacy Study of Daptomycin in Complicated Skin and Skin Structure Infections

Who this might be right for
Soft Tissue Infections
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 100
Early research (Phase 1)Study completedNCT00858325
What this trial is testing

Pharmacokinetic Study of Daptomycin in Healthy Chinese Subjects Living in China

Who this might be right for
Healthy
AstraZeneca 24
Large-scale testing (Phase 3)Ended earlyNCT01455246
What this trial is testing

Daptomycin + Meropenem Versus Ceftazidime in the Treatment of Nosocomial Spontaneous Bacterial Peritonitis

Who this might be right for
CirrhosisAscitesNosocomial Spontaneous Bacterial Peritonitis
University of Padova 32
Large-scale testing (Phase 3)Study completedNCT01922011
What this trial is testing

Safety and Efficacy Study of Daptomycin Compared to Active Comparator in Pediatric Participants With Acute Hematogenous Osteomyelitis (AHO) (MK-3009-006)

Who this might be right for
Acute Hematogenous Osteomyelitis
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 149
Post-approval studies (Phase 4)Study completedNCT01080963
What this trial is testing

Daptomycin as Antibiotic Prophylaxis of Sternal Wound Infections

Who this might be right for
Wound Infection
Hannover Medical School 650
Not applicableUnknownNCT01314053
What this trial is testing

Retrospective Evaluation of Safety and Efficacy of Daptomycin Used in Patients With Serious Gram-positive Infections

Who this might be right for
Serious Gram-positive Infections
Taipei Medical University WanFang Hospital 60
Not applicableStudy completedNCT03209934
What this trial is testing

Daptomycin > 6 mg/kg/Day as Salvage Therapy in Patients With Complex Bone and Joint Infection: Cohort Study in a Regionalreference Center

Who this might be right for
Bone and Joint InfectionTreated by Daptomycin
Hospices Civils de Lyon 43
Testing effectiveness (Phase 2)Study completedNCT00335478
What this trial is testing

Daptomycin in Treating Neutropenia and Fever in Patients With Cancer

Who this might be right for
FeverSweatingHot Flashes+3 more
OHSU Knight Cancer Institute 54
Post-approval studies (Phase 4)WithdrawnNCT02241941
What this trial is testing

Evaluation of Single-dose Pharmacokinetics of Intravenous Daptomycin in Patients With Thermal Injury

Who this might be right for
Burn Injury
University of Zurich
Testing effectiveness (Phase 2)Study completedNCT03643952
What this trial is testing

Safety, Efficacy, and Pharmacokinetics (PK) of Daptomycin (MK-3009) in Japanese Pediatric Subjects With Complicated Skin and Soft Tissue Infections (cSSTI) and Bacteremia (MK-3009-029)

Who this might be right for
BacteremiaSoft Tissue InfectionsSkin Diseases, Infectious
Merck Sharp & Dohme LLC 18
Post-approval studies (Phase 4)Study completedNCT01728376
What this trial is testing

Safety & Efficacy of Daptomycin Versus Standard of Care (SOC) in 1 - 17 Year Olds With Staphylococcus Aureus Bacteremia (MK-3009-005)

Who this might be right for
Bacteremia
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 82
Not applicableUnknownNCT04933344
What this trial is testing

Pharmacokinetics and Toxicodynamics of Daptomycin in Bone and Joint Infections

Who this might be right for
Dactinomycin Adverse ReactionBone and Joint Infection
Hospices Civils de Lyon 1,130
Early research (Phase 1)Study completedNCT04434300
What this trial is testing

Subcutaneous Daptomycin in Healthy Volunteers (DAPTOSC)

Who this might be right for
AntibioticsSubcutaneous InjectionDaptomycin
University Hospital, Caen 12
Testing effectiveness (Phase 2)Study completedNCT00467272
What this trial is testing

Catheter Related - Gram Positive Bloodstream Infections

Who this might be right for
Bloodstream Infection
M.D. Anderson Cancer Center 30
Large-scale testing (Phase 3)Ended earlyNCT00055198
What this trial is testing

Daptomycin for the Treatment of Infections Due to Gram-Positive Bacteria

Who this might be right for
Gram-Positive Bacterial Infections
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 75
Next Page